High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer

High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer

Breast cancer constitutes the leading cause of cancer deaths among females. However, numerous shortcomings, including low bioavailability, resistance and significant side effects, are responsible for insufficient treatment. The ultimate goal, therefore, is to improve the success rates and, thus, the...

Full description

Bibliographic Details
Main Authors: Inken Flörkemeier, Tamara N. Steinhauer, Nina Hedemann, Jörg Paul Weimer, Christoph Rogmans, Marion T. van Mackelenbergh, Nicolai Maass, Bernd Clement, Dirk O. Bauerschlag
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
breast cancer
drug development
dual topoisomerase inhibitor
apoptosis
2D
3D
Online Access:https://www.mdpi.com/2072-6694/14/1/2

Internet

https://www.mdpi.com/2072-6694/14/1/2

Similar Items